Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.12.03.471045
PubMed Identifier: 34981049
Publication URI: http://europepmc.org/abstract/MED/34981049
Type: Journal Article/Review
Parent Publication: bioRxiv : the preprint server for biology